161
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Screening of Some Indicators for Alpha-Thalassemia in Fujian Province of Southern China

ORCID Icon, , ORCID Icon, , , , & ORCID Icon show all
Pages 7329-7335 | Published online: 28 Oct 2021

References

  • Muncie HL Jr, JS Campbell. Alpha and Beta Thalassemia . Am Fam Physician. 2009;80(4):339–344.
  • Dong BQ, Chen BY, Liang QY, et al. Study on the characteristics of major birth defects in 1.69 million cases of fetus in Guangxi Zhuang Autonomous Region. Zhonghua Liu Xing Bing Xue Za Zhi. 2019;40(12):1554–1559.
  • Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704–712.
  • Baysal E. Alpha-thalassemia syndromes in the United Arab Emirates. Hemoglobin. 2011;35(5–6):574–580. doi:10.3109/03630269.2011.634698
  • Alkindi S, Al Zadjali S, Al Madhani A, et al. Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates. Hemoglobin. 2010;34(2):135–144. doi:10.3109/03630261003677213
  • He S, Li J, Li DM, et al. Molecular characterization of alpha- and beta-thalassemia in the Yulin region of Southern China. Gene. 2018;655:61–64. doi:10.1016/j.gene.2018.02.058
  • Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018;391(10116):155–167. doi:10.1016/S0140-6736(17)31822-6
  • Xu LP, Huang HL, Wang Y, et al. Molecular epidemiological analysis of alpha- and beta-thalassemia in Fujian province. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013;30(4):403–406.
  • Waye CD, Waye JS. Hydrops fetalis caused by alpha-thalassemia: an emerging health care problem. Blood. 1998;91(7):2213–2222. doi:10.1182/blood.V91.7.2213
  • Choudhry VP. Quality of life in thalassemia major. Indian J Pediatr. 2018;85(11):957–958. doi:10.1007/s12098-018-2792-z
  • Yao XY, Yu J, Chen SP, et al. Prevalence and genetic analysis of alpha-thalassemia and beta-thalassemia in Chongqing area of China. Gene. 2013;532(1):120–124. doi:10.1016/j.gene.2013.09.031
  • Angelucci E, Matthes-Martin S, Baronciani D, et al. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel. Haematologica. 2014;99(5):811–820. doi:10.3324/haematol.2013.099747
  • Algiraigri AH, Wright NAM, Paolucci EO, A Kassam Hydroxyurea for nontransfusion-dependent beta-thalassemia: a systematic review and meta-analysis. Hematol Oncol Stem Cell Ther. 2017;10(3):116–125. doi:10.1016/j.hemonc.2017.02.002
  • Srivastava A, Shaji RV. Cure for thalassemia major - from allogeneic hematopoietic stem cell transplantation to gene therapy. Haematologica. 2017;102(2):214–223. doi:10.3324/haematol.2015.141200
  • Ferrari G, CavazzanaF Mavilio M. Gene therapy approaches to hemoglobinopathies. Hematol Oncol Clin North Am. 2017;31(5):835–852. doi:10.1016/j.hoc.2017.06.010
  • Ryan K, Bain BJ, Worthington D, et al. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol. 2010;149(1):35–49. doi:10.1111/j.1365-2141.2009.08054.x
  • Xu C, Liao B, Qi Y, et al. Analysis of gene mutation types of alpha- and beta-thalassemia in Fuzhou, Fujian Province in China. Hemoglobin. 2018;42(3):143–147. doi:10.1080/03630269.2018.1496096
  • Chong SS, Boehm CD, Cutting GR, Higgs DR. Simplified multiplex-PCR diagnosis of common Southeast Asian deletional determinants of alpha-thalassemia. Clin Chem. 2000;46(10):1692–1695. doi:10.1093/clinchem/46.10.1692
  • Wang W, Chan AY, Chan LC, MaS ES, Chong S. Unusual rearrangement of the alpha-globin gene cluster containing both the -alpha3.7 and alphaalphaalphaanti-4.2 crossover junctions: clinical diagnostic implications and possible mechanisms. Clin Chem. 2005;51(11):2167–2170. doi:10.1373/clinchem.2005.054189
  • Zeng YT, Huang SZ. Alpha-globin gene organisation and prenatal diagnosis of alpha-thalassaemia in Chinese. Lancet. 1985;1(8424):304–307.
  • Lal A, Goldrich ML, Haines DA, et al. Heterogeneity of hemoglobin H disease in childhood. N Engl J Med. 2011;364(8):710–718. doi:10.1056/NEJMoa1010174
  • Vichinsky E. Advances in the treatment of alpha-thalassemia. Blood Rev. 2012;26(Suppl 1):S31–34. doi:10.1016/S0268-960X(12)70010-3
  • Lin M, Wang Q, Zheng L, et al. Prevalence and molecular characterization of abnormal hemoglobin in eastern Guangdong of southern China. Clin Genet. 2012;81(2):165–171. doi:10.1111/j.1399-0004.2011.01627.x
  • Zheng CG, Liu M, Du J, et al. Molecular spectrum of alpha- and beta-globin gene mutations detected in the population of Guangxi Zhuang Autonomous Region, People’s Republic of China. Hemoglobin. 2011;35(1):28–39. doi:10.3109/03630269.2010.547429
  • Phanmany S, Chanprasert S, Munkongdee T, Svasti S, K Leecharoenkiat. Molecular prevalence of thalassemia and hemoglobinopathies among the Lao Loum Group in the Lao People’s Democratic Republic. Int J Lab Hematol. 2019;41(5):650–656. doi:10.1111/ijlh.13080
  • Bain BJ. Haemoglobinopathy diagnosis: algorithms, lessons and pitfalls. Blood Rev. 2011;25(5):205–213. doi:10.1016/j.blre.2011.04.001
  • Karnpean R, Pansuwan A, Fucharoen G, Fucharoen S. Evaluation of the URIT-2900 automated hematology analyzer for screening of thalassemia and hemoglobinopathies in Southeast Asian populations. Clin Biochem. 2011;44(10–11):889–893. doi:10.1016/j.clinbiochem.2011.04.009